This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Las genuinas responsabilidades de la dirección general
Andreu Civit, Rafael; Ricart Costa, Joan EnricArticle ART-2639Innovation and Change, Leadership and People Management, StrategyUn director general debe tocar muchas y muy variadas teclas. Pero no todas son igualmente relevantes. Los autores identifican cuatro grandes prioridades de la dirección general y otras tantas tareas básicas. Pero advierten que es imprescindible entenderlas y gestionarlas todas como un conjunto inseparable de elementos interdependientes cuya dinámica es especialmente relevante. Asimismo, señalan la necesidad de hacerlo con disciplina en las decisi...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
The Genuine Responsibilities of the CEO
Andreu Civit, Rafael; Ricart Costa, Joan EnricArticle ART-2639-EInnovation and Change, Leadership and People Management, StrategyA CEO must pull many levers, but not all are equally relevant. Based on hundreds of interviews they conducted with senior executives, the authors identify four main priorities for general management, corresponding with four primary tasks. They caution, however, that executives must understand and manage them all as an inseparable whole of interdependent, highly dynamic elements. They also emphasize that CEOs need to be disciplined in their decisi...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00